-
FDA, EMA Accept to Review Siponimod as Treatment for SPMS
U.S. and European regulatory agencies have agreed to review the Novartis therapy siponimod to treat SPMS. Click here to find out more about these findings.
What are your thoughts on this news?
-
1 Reply
-
I’m glad that they’re going to review siponimod and I hope they find the medication is useful for SPMS. People with Secondary Progressive need more treatments that are approved to treat them.
Ed
Log in to reply.